Search research articles
Contact Us
Filters
Showing results (121-130 of 164) with videos related to
Page
of 17
Sort By:
Brain & Development
|
May 12, 2020
Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG
C Paketci, P Edem, S Hiz, et al.
Neuromuscular Disorders : NMD
|
February 26, 2013
Initial development and validation of a mitochondrial disease quality of life scale
J L Elson, M Cadogan, S Apabhai, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 5, 2016
Biomarker development targeting unmet clinical needs
Phillip J Monaghan, Sarah J Lord, Andrew St John, et al.
Microbiology Spectrum
|
June 6, 2022
Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
Diana D Wong, Wendy J van Zuylen, Talia Novos, et al.
Cell Death & Disease
|
November 30, 2024
OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution
J Macuada, I Molina-Riquelme, G Vidal, et al.
JAMA Internal Medicine
|
May 16, 2017
Guidance for Modifying the Definition of Diseases: A Checklist
Jenny Doust, Per O Vandvik, Amir Qaseem, et al.
EJIFCC
|
July 28, 2018
Practical guide for identifying unmet clinical needs for biomarkers
Phillip J Monaghan, Sarah Robinson, Daniel Rajdl, et al.
Journal of Medicinal Chemistry
|
February 28, 1997
Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands
S N Calderon, K C Rice, R B Rothman, et al.
Neurology
|
November 26, 2008
OPA1 in multiple mitochondrial DNA deletion disorders
J D Stewart, G Hudson, P Yu-Wai-Man, et al.
Human Molecular Genetics
|
December 26, 2001
Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts
M Jaksch, C Paret, R Stucka, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 164) with videos related to
Sort By:
Page
of 17
Brain & Development
|
May 12, 2020
Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG
C Paketci, P Edem, S Hiz, et al.
Neuromuscular Disorders : NMD
|
February 26, 2013
Initial development and validation of a mitochondrial disease quality of life scale
J L Elson, M Cadogan, S Apabhai, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 5, 2016
Biomarker development targeting unmet clinical needs
Phillip J Monaghan, Sarah J Lord, Andrew St John, et al.
Microbiology Spectrum
|
June 6, 2022
Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
Diana D Wong, Wendy J van Zuylen, Talia Novos, et al.
Cell Death & Disease
|
November 30, 2024
OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution
J Macuada, I Molina-Riquelme, G Vidal, et al.
JAMA Internal Medicine
|
May 16, 2017
Guidance for Modifying the Definition of Diseases: A Checklist
Jenny Doust, Per O Vandvik, Amir Qaseem, et al.
EJIFCC
|
July 28, 2018
Practical guide for identifying unmet clinical needs for biomarkers
Phillip J Monaghan, Sarah Robinson, Daniel Rajdl, et al.
Journal of Medicinal Chemistry
|
February 28, 1997
Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands
S N Calderon, K C Rice, R B Rothman, et al.
Neurology
|
November 26, 2008
OPA1 in multiple mitochondrial DNA deletion disorders
J D Stewart, G Hudson, P Yu-Wai-Man, et al.
Human Molecular Genetics
|
December 26, 2001
Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts
M Jaksch, C Paret, R Stucka, et al.
Page
of 17